Abstract
Accumulated evidence suggests that polyphenolic antioxidants present in herbs play important roles in prevention of AD; the molecular mechanisms behind neuroprotective actions rely on the phenols through different effects on the amyloid-aggregation pathway. Fagopyrum dibotrys is a traditional herbal medicine which contains high quantity phenols. In present study, we investigate the beneficial pharmacological actions of Fagopyrum dibotrys extract in the APP/PS1 transgenic mouse mode; meanwhile, effects of the FDE on the fibrillation and cytotoxicity of Aβ peptide were evaluated in vitro. After 9-month treatment, FDE exhibited multifunctional properties on Aβ-related pathologies, which cleaned Aβ deposits in the brain and decreased Aβ burden in the plasma, inhibited microhaemorrhage, and reduced reactive microglia in APP/PS1 transgenic mice and also promoted Aβ fibrils disaggregation and inhibited neurotoxicity induced by Aβ in SH-SY5Y cells. These results highlighted that FDE is an AD type pathology modulator with therapeutic potential against AD.
References
May 5, 2001·Biomolecular Engineering·J L JankowskyD R Borchelt
Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Sep 9, 2006·Brain Research Reviews·Petrea FridNatalija Popovic
Jan 16, 2007·Journal of Neuroimmunology·Michael T Heneka, M Kerry O'Banion
Oct 22, 2008·Genes & Nutrition·David VauzourJeremy P E Spencer
Nov 7, 2009·The American Journal of Pathology·Tsuyoshi HamaguchiMasahito Yamada
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Aug 19, 2010·Oxidative Medicine and Cellular Longevity·Kanti Bhooshan Pandey, Syed Ibrahim Rizvi
Feb 11, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan-Jiang WangXin-Fu Zhou
Dec 23, 2011·Annals of Neurology·Anand Viswanathan, Steven M Greenberg
Jun 16, 2012·Oxidative Medicine and Cellular Longevity·David Vauzour
Feb 15, 2013·PloS One·Takashi MoriTerrence Town
Mar 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Simantini GhoshM Kerry O'Banion
May 25, 2013·Clinical Pharmacokinetics·Christian UdeMario Wurglics
May 23, 2014·Frontiers in Neurology·Yue-Qin ZengXin-Fu Zhou
Oct 16, 2014·Biochimica Et Biophysica Acta·Giulio Maria PasinettiLauren Dubner
Dec 2, 2014·Expert Opinion on Therapeutic Targets·Patrick L McGeer, Edith G McGeer
Mar 21, 2015·Lancet Neurology·Michael T HenekaMarkus P Kummer